Norway Donates NOK 600M To IFFIm To Support CEPI’s Vaccine Development Efforts

Gavi, the Vaccine Alliance: Kingdom of Norway contributes NOK 600 million to IFFIm
“The Kingdom of Norway has agreed to donate NOK 600 million to the International Finance Facility for Immunisation (IFFIm). The donation is intended to support the Coalition for Epidemic Preparedness Innovation (CEPI). In a novel arrangement approved by Gavi, the Vaccine Alliance, IFFIm is planning to issue bonds on international capital markets, backed by the donation from Norway, which hosts CEPI. … CEPI’s immediate mandate is to develop vaccines for six diseases with outbreak potential: Nipah Virus, Lassa Fever, Disease X, Rift Valley fever, Chikungunya, and Middle East Respiratory Syndrome (MERS). CEPI is coordinating the development of these new vaccines and will eventually make them available at affordable prices to low-income countries disproportionately affected by these epidemics…” (5/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.